Browsing: COVID-19 Pandemic

The latest news effecting cancer patients and oncology service delivery during the COVID-19 pandemic

In patients with cancer and COVID-19, cancer that is progressing was independently associated with an increased risk of death, according to an analysis of 928 patients. COVID-19 treatment with both hydroxychloroquine and azithromycin was also strongly associated with increased risk of death, according to data from the COVID-19 and Cancer Consortium (CCC19) registry. The registry contains data from patients who have tested positive for COVID-19 and around 40% of patients in the registry also have active cancer. The data was presented as part of the virtual scientific program of the 2020 American Society of Clinical Oncology (ASCO) Annual Meeting. “The…

The American Society of Clinical Oncology (ASCO) recently released the ASCO Special Report: A Guide to Cancer Care Delivery During the COVID-19 Pandemic, which provides detailed guidance to oncology practices on the immediate and short-term steps that could be taken to help protect the safety of patients and healthcare staff before resuming more routine care operations during the COVID-19 public health crisis. The COVID-19 pandemic has required oncology practices in nearly every community across the United States to make operational changes to protect the safety of patients and staff, adjust to resource shortages, and comply with national and state restrictions…

Cancer Council NSW is launching a new series of its popular podcasts, this time focused on the most common issues for cancer patients during the COVID-19 pandemic. Called Cancer and COVID-19, the series features health professionals from our 13 11 20 service and explores some of the most common questions they’ve been asked by patients and carers navigating a cancer diagnosis through the pandemic. Three episodes are available now, covering: Coping with Isolation and Cancer during COVID-19: What does social distancing mean for people affected by cancer? How can you stay connected with your support circle? 13 11 20 consultant…

The novel coronavirus (COVID-19) pandemic not only affects patients who have the virus, but strikes the entire healthcare system including the care for patients with cancer. Aggressive cancers, such as pancreatic cancer, require the continuation of oncological care during the pandemic. However, pursuing care exposes both healthcare professionals and vulnerable patients to COVID-19. Today, new research published in Annals of Surgery from the University of Colorado Department of Surgery at the Anschutz Medical Campus, USA, provides guidance on clinical decision-making in regards to treating pancreatic cancer patients during the COVID-19 pandemic. “The inability to receive medical or surgical care during a…

Lung cancer patients are at heightened risk for COVID-19 and the reported high mortality rate among lung cancer patients with COVID-19 has given pause to oncologists who are faced with patients with not one, but two severe, life-threatening diseases. To help oncologists address the many challenges COVID-19-positive lung cancer patients present, a team of global lung cancer specialists this week published a review of lung cancer treatments for patients with COVID-19 in the current issue of the Journal of Thoracic Oncology, the official journal of the International Association for the Study of Lung Cancer (IASLC). “The purpose of this manuscript is…

Delays to cancer surgery and other treatment caused by the Covid-19 crisis could result in thousands of additional deaths linked to the pandemic in England, UK, a major new study reports. New modelling has revealed the extent of the impact that disruption to the cancer care and diagnosis pathway could have on the survival of cancer patients. Many cancer patients may end up experiencing delays of several months to their cancer treatment in the context of the pandemic – including in operations to remove tumours. Those patients whose cancer will have progressed during the delay and who might otherwise have…

Despite facing challenges such as limited access to personal protective equipment (PPE) following the COVID-19 outbreak, radiation oncology clinics quickly implemented safety and process enhancements that allowed them to continue caring for cancer patients, according to a new US survey from the American Society for Radiation Oncology (ASTRO). All 222 physician leaders in the survey, which was in the field April 16-30, said their practices continued to provide radiation therapy services during the early weeks of the pandemic, yet 85% also reported declines in the number of patients seen, by an average of one-third. Once the COVID-19 threat was apparent,…

A new study will look at how patients, who receive stem cell transplants for blood cancers and blood disorders, react to COVID-19 infection during their recovery. Announced by IMPACT, a partnership of organisations committed to improving the survival rates of stem cell transplant patients by increasing the number of clinical trials across the UK, the study will: Characterise the immune response of stem cell transplant patients to severe COVID-19 infection and the possible impact of ongoing immunosuppressive treatments. Identify measurable biomarkers from blood samples that can be used to predict patient survival and identify those at the biggest risk. Determine…

By Dr Ursula Sansom-Daly and A/Prof Caroline Ford The societal lock-down in response to the COVID-19 pandemic has triggered much discussion around gender equity in workplaces, with many parents now finding themselves juggling working from home with looking after young children and/or attempting to become a home-school teacher, principal and school counsellor all rolled into one. As has been noted elsewhere,[1,2] these new dynamics may serve to democratise home workloads between partners or may instead further exacerbate unequal sharing of duties. There is little doubt that for many women in STEMM, who already encounter systems with ingrained bias against them, this…

QIMR Berghofer scientists are urging Queenslanders who have recovered from COVID-19 to help them discover how the human immune system fights the disease – and hopefully develop immunotherapies to treat very sick patients. There have been 1052 confirmed cases in Queensland with six deaths – but 1028 people have recovered to date. The researchers are calling on 50 adults from southeast Queensland, who tested positive to the virus and have subsequently recovered and been released from quarantine, to take part. Volunteers will need to visit one of 11 participating pathology laboratories in Brisbane, Ipswich or on the Gold Coast to…

1 15 16 17 18 19 20